Decreasing the number of undiagnosed HIV infections is one of the objectives of Australia's Seventh National HIV Strategy. 3 According to national surveillance data, up to In 2012 and 2013, Australia had the highest incidence of HIV diagnoses in 20 years. 1 While there is no imminent threat of a generalised epidemic in Australia, the recent increase in HIV diagnoses reflects changing infection patterns that warrant an exploration of current testing practices. Opt-out HIV testing could decrease the number of undiagnosed infections and provide for timely connection to care.
Opt-out testing is a method for detecting disease in which patients are informed that they will be tested for the disease unless they decline. In opt-out HIV testing, patients in the general population between the ages of 13 and 64 years are tested for HIV at least once in their lifetime in a routine health encounter, such as at a GP consultation or emergency department visit. Testing that occurs outside of dedicated HIV testing centres can capture a broader section of the population, including those who test infrequently or perceive themselves as low risk. A range of testing settings is necessary because even sexual health services do not identify all HIV infections. A study conducted in Canberra in 2006 found that 58 per cent of HIV-infected people had attended a sexual health clinic prior to the consultation that led to their diagnosis. In the same study, 95 per cent of patients had presented with risk factors that warranted HIV testing, but testing did not occur until later. 6 Societal factors such as Australia's resource boom have resulted in increased mobility and disposable income. It is not unusual for Australians to live for extended periods in countries with higher HIV prevalence. There has been an increase in heterosexual HIV transmission among male fly-in, fly-out workers from Western Australia and Northern Territory who travel frequently to Thailand and Indonesia. 1 Cultural and social factors identified by Brown 7 make it unlikely that this group would self-select for HIV testing. Any infections in this group could be identified earlier by conducting opt-out HIV testing in places where they are most likely to seek general medical care (such as occupational health, general practice, or emergency departments).
Cost-effectiveness modelling would be required before optout HIV testing could be implemented throughout Australia. Cost effectiveness varies with disease prevalence, which for HIV is presently 0.15 per cent among Australians over age 15. 1 Research from the US has shown that opt-out testing is cost effective even at 0.05 per cent prevalence. 8 A French study found that one-time, routine HIV testing in the general population was similar in cost effectiveness to other screening programs such as annual chlamydia testing in young adults. 5 These findings may not be generalisable to Australia because of differences in health systems and disease patterns, but modelling showed that opt-out testing among Australian pregnant women is cost effective at prevalence rates greater than 0.004 per cent. 9 As with any diagnostic investigation, an opt-out HIV testing program must ensure compliance with state and national laws, informed consent, and patient confidentiality procedures. Health providers should perform and document thorough pre-and post-test counselling and facilitate immediate referrals to HIV treatment centres in case of positive results. Since optout HIV testing is performed without clinical suspicion or risk factor assessment, HIV diagnoses with this approach (though infrequent) would likely be unanticipated. 13 Consequently, opt-out testing protocols must mitigate the potential effects of diagnostic labelling (such as stigmatisation) and address the mental health consequences of the testing or results (such as self-harm or harm to an individual believed to have transmitted the infection). 10, 11, 13 Psychosocial support for newly diagnosed individuals is essential for self-management and engagement with treatment. 12 An opt-out testing program should use HIV tests with a high specificity to minimise false positives, which are more common in populations with lower disease prevalence.
In opt-out HIV testing, the onus is on the patient to decline the test. Research from the US and UK has shown that most patients are willing to be tested. 14 However, it is essential that there is no coercion or negative consequence for patients who do not wish to test. [10] [11] [12] [13] Opt-out testing in the US was facilitated by Centers for Disease Control funding for dedicated staff to perform testing and counselling. Australia may have other priorities for scarce healthcare resources. We are conducting a two-phase feasibility study of opt-out HIV testing in GP practices. Preliminary findings suggest that healthcare providers see public health benefits to opt-out HIV testing, but are concerned about the increased workload and potential for pre-test counselling to be overlooked.
The Seventh National HIV Strategy aims to sustain Australia's low prevalence of HIV, but its emphasis on targeted, risk factor-based testing should be reconsidered. International and preliminary Australian evidence indicates that opt-out HIV testing is acceptable and cost effective. Given the recent increase in HIV diagnoses in Australia, this is an opportune time to explore the feasibility of opt-out HIV testing to improve early diagnosis and connection to care in non-traditional populations.
